The pharmaceutical industry continually seeks novel and efficient chemical synthesis routes to produce complex drug molecules. Traditional synthetic pathways often involve multiple steps, leading to low yields and increased costs. To mitigate these challenges, researchers are exploring innovative strategies, such as organocatalysis, to develop more